Overview
Swiss automation solutions firm's 2025 net sales rose 2.1% to CHF 381.9 mln
Operating profit margin improved to 10.3% from 8.5%
Order intake fell 14.4% due to cautious investment behavior
Outlook
Mikron forecasts 2026 net sales between CHF 340 mln and CHF 380 mln
Mikron expects 2026 operating profit margin of 7% to 10%
Company sees temporary reduction in Automation order intake
Result Drivers
PHARMA AND MEDTECH SALES - Pharmaceutical and medtech industries drove net sales growth, accounting for 66% of total sales
AUTOMATION SALES IN EUROPE - Increased Automation sales in Europe boosted operating profit
ORDER INTAKE CHALLENGES - Decline in order intake due to extended decision processes and geopolitical uncertainties
Company press release: ID:nEQ6dykrga
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
FY EBIT | CHF 39.5 mln | ||
FY EBIT Margin | 10.3% | ||
FY Orders | CHF 332.7 mln |
Analyst Coverage
The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 14 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Comments